{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:31:50Z","timestamp":1793223110635,"version":"4.5.0"},"reference-count":341,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":266,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ctarc.2024.100845","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T22:06:52Z","timestamp":1727129212000},"page":"100845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"special_numbering":"C","title":["Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7385-7952","authenticated-orcid":false,"given":"Tajul Islam","family":"Mamun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Younus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Hashibur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2024.100845_bib0001","first-page":"47","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100845_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18457","article-title":"Global incidence and mortality of gastric cancer, 1980-2018","volume":"4","author":"Wong","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0004","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/ajco.13654","article-title":"Overview of epidemiological characteristics, clinical features, and risk factors of gastric cancer in Asia-Pacific region","volume":"18","author":"Akbari","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0006","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.7150\/jca.51433","article-title":"Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer","volume":"12","author":"Lv","year":"2021","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0007","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctarc.2024.100845_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103841","article-title":"Characteristics of gastric cancer around the world","volume":"181","author":"L\u00f3pez","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"20","key":"10.1016\/j.ctarc.2024.100845_bib0009","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.3390\/nu14204260","article-title":"Effect of dietary salt intake on risk of gastric cancer: a systematic review and meta-analysis of case-control studies","volume":"14","author":"Wu","year":"2022","journal-title":"Nutrients."},{"key":"10.1016\/j.ctarc.2024.100845_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109365","article-title":"Alcohol consumption and risk of stomach cancer: a meta-analysis","volume":"336","author":"Deng","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21147\/j.issn.1000-9604.2021.01.02","article-title":"Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: findings from global burden of disease study","volume":"33","author":"Zhang","year":"2021","journal-title":"Chin. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0013","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.6004\/jnccn.2016.0137","article-title":"Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Ajani","year":"2016","journal-title":"J. Natl. Compreh. Cancer Netw."},{"issue":"10294","key":"10.1016\/j.ctarc.2024.100845_bib0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ctarc.2024.100845_bib0015","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.3390\/jcm11154337","article-title":"Gastric cancer screening in Japan: a narrative review","volume":"11","author":"Yashima","year":"2022","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0016","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ctarc.2024.100845_bib0017","first-page":"1","article-title":"Burden of stomach cancer incidence, mortality, disability-adjusted life years, and risk factors in 204 countries, 1990\u20132019: an examination of Global Burden of Disease 2019","author":"Sharma","year":"2024","journal-title":"J. Gastrointest. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0018","first-page":"229","article-title":"Changing trends in the epidemiology of gastric cancer","volume":"96","author":"Grad","year":"2023","journal-title":"Med. Pharm. Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0019","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of gastric cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0020","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1002\/cam4.5685","article-title":"Trends in gastric cancer mortality 1990\u20132019 in 36 countries worldwide, with predictions to 2025, and incidence, overall and by subtype","volume":"12","author":"Collatuzzo","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2024.100845_bib0021","first-page":"865","article-title":"Comparison between registries: age-standardized rates","author":"Smith","year":"1992","journal-title":"Cancer Incid. Five Continent."},{"key":"10.1016\/j.ctarc.2024.100845_bib0022","unstructured":"Surveillance, E., and End Results Program. Cancer Stat Facts: stomach Cancer. [cited 2024 24 July]; Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/stomach.html."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100845_bib0023","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/ijc.34158","article-title":"Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype","volume":"151","author":"Wang","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2468-1253(19)30328-0","article-title":"The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: a systematic analysis for the Global Burden of Disease study 2017","volume":"5","author":"Etemadi","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/whr.2023.0069","article-title":"Predictive factors associated with survival in female gastric cancer patients in Southeast Asia","volume":"5","author":"Bongkotvirawan","year":"2024","journal-title":"Women's Health Rep."},{"key":"10.1016\/j.ctarc.2024.100845_bib0026","unstructured":"Institute, N.C. Stomach cancer survival rates and prognosis. May 31, 2023 [cited 2024 25 July]; Available from: https:\/\/www.cancer.gov\/types\/stomach\/survival#:\u223c:text=Stomach%20Cancer%20Statistics&text=75%25%20for%20localized%20stomach%20cancer,distant%20part%20of%20the%20body)."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0027","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5114\/pg.2018.80001","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterol. Rev.\/Przegl\u0105d Gastroenterol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0028","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","year":"2019","journal-title":"JAMa Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0029","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/cam4.3892","article-title":"Chinese and global burdens of gastric cancer from 1990 to 2019","volume":"10","author":"He","year":"2021","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100845_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061038","article-title":"Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA","volume":"12","author":"Wu","year":"2022","journal-title":"BMJ Open."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0031","first-page":"397","article-title":"Global burden prediction of gastric cancer during demographic transition from 2020 to 2040","volume":"136","author":"Yan","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ctarc.2024.100845_bib0032","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0033","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0034","unstructured":"Society, A.C. Stomach cancer survival rates. [cited 2024 27 July]; Available from: https:\/\/www.cancer.org\/cancer\/types\/stomach-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"issue":"10125","key":"10.1016\/j.ctarc.2024.100845_bib0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2024.100845_bib0036","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10120-018-0826-x","article-title":"Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States","volume":"21","author":"De","year":"2018","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0037","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/apt.12814","article-title":"The epidemiology and prevention of gastric cancer","volume":"40","author":"Fock","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ctarc.2024.100845_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-021-00340-6","article-title":"Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia","volume":"9","author":"Yang","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ctarc.2024.100845_bib0039","doi-asserted-by":"crossref","DOI":"10.1177\/10732748221099227","article-title":"Recent estimates and predictions of 5-year survival in patients with gastric cancer: a model-based period analysis","volume":"29","author":"Li","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.ctarc.2024.100845_bib0040","unstructured":"UK, C.R. Stomach cancer incidence statistics. [cited 2024 22 April]; Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/stomach-cancer\/incidence."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0041","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.gtc.2016.04.002","article-title":"Current perspectives on gastric cancer","volume":"45","author":"Marques-Lespier","year":"2016","journal-title":"Gastroenterol. Clin."},{"key":"10.1016\/j.ctarc.2024.100845_bib0042","article-title":"National cancer institute, DCCPS","author":"Surveillance","year":"2022","journal-title":"Surveil. Res. Prog."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0043","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s11605-019-04304-y","article-title":"Gender differences in gastric cancer survival: 99,922 cases based on the SEER database","volume":"24","author":"Li","year":"2020","journal-title":"J. Gastrointest. Surg."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0044","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/annonc\/mdt279","article-title":"Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study","volume":"24","author":"Tabuchi","year":"2013","journal-title":"Annal. Oncol."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0045","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1158\/1055-9965.EPI-13-0805-T","article-title":"Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study","volume":"22","author":"Tao","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0046","doi-asserted-by":"crossref","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","article-title":"Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology","volume":"16","author":"Gradishar","year":"2018","journal-title":"J. Natl. Compreh. Cancer Netw."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0047","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4251\/wjgo.v10.i5.115","article-title":"Risk of gastric cancer development after eradication of Helicobacter pylori","volume":"10","author":"Cheung","year":"2018","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0048","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4143\/crt.2020.610","article-title":"Population attributable fraction of helicobacter pylori infection\u2013related gastric Cancer in Korea: a meta-analysis","volume":"53","author":"Park","year":"2021","journal-title":"Cancer Res. Treat.: Off. J. Korean Cancer Assoc."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0049","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3390\/ijms24032895","article-title":"Helicobacter pylori and gastric cancer: pathogenetic mechanisms","volume":"24","author":"Salvatori","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0051","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/microorganisms11051312","article-title":"Helicobacter pylori and its role in gastric cancer","volume":"11","author":"Reyes","year":"2023","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0052","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0053","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","article-title":"Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota","volume":"67","author":"Ferreira","year":"2018","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0054","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrc2857","article-title":"Helicobacter pylori: gastric cancer and beyond","volume":"10","author":"Polk","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0055","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2468-2667(21)00164-X","article-title":"The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study","volume":"6","author":"Yang","year":"2021","journal-title":"Lancet Public Health"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0056","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jgh3.12714","article-title":"Relative risk of gastric cancer between those with and without Helicobacter pylori infection history in Japan","volume":"6","author":"Kikuchi","year":"2022","journal-title":"JGH Open"},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0057","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/antibiotics11081052","article-title":"Decreasing incidence of gastric cancer with increasing time after helicobacter pylori treatment: a nationwide population-based cohort study","volume":"11","author":"Kim","year":"2022","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0058","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2019.04.011","article-title":"Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics","volume":"157","author":"Fallone","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0059","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.chom.2014.02.008","article-title":"Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis","volume":"15","author":"Hatakeyama","year":"2014","journal-title":"Cell Host. Microbe."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0060","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2169\/internalmedicine.47.0975","article-title":"Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains","volume":"47","author":"Yamaoka","year":"2008","journal-title":"Internal. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0061","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01869-15","article-title":"Helicobacter pylori diversity and gastric cancer risk","volume":"7","author":"Cover","year":"2016","journal-title":"mBio"},{"issue":"9636","key":"10.1016\/j.ctarc.2024.100845_bib0062","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial","volume":"372","author":"Fukase","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2024.100845_bib0063","first-page":"348","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials","author":"Ford","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ctarc.2024.100845_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41021-021-00174-6","article-title":"Panel of significant risk factors predicts early stage gastric cancer and indication of poor prognostic association with pathogens and microsatellite stability","volume":"43","author":"Chakraborty","year":"2021","journal-title":"Genes Environ."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13167-022-00308-y","article-title":"Global burden of cancers attributable to tobacco smoking, 1990\u20132019: an ecological study","volume":"14","author":"Sharma","year":"2023","journal-title":"EPMA J."},{"key":"10.1016\/j.ctarc.2024.100845_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1224753","article-title":"Lifestyle habits and gastric cancer in an East Asian population: a Mendelian randomization study","volume":"13","author":"Tan","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0067","doi-asserted-by":"crossref","first-page":"FSO394","DOI":"10.2144\/fsoa-2019-0017","article-title":"The effects of cigarette smoking extracts on cell cycle and tumor spread: novel evidence","volume":"5","author":"Pezzuto","year":"2019","journal-title":"Future Sci. Oa."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0068","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12885-022-09894-6","article-title":"A prospective cohort study on the association between waterpipe tobacco smoking and gastric cancer mortality in Northern Vietnam","volume":"22","author":"Le","year":"2022","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0069","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.31557\/APJCP.2022.23.5.1587","article-title":"Waterpipe tobacco smoking and risk of stomach cancer: a case-control study in Vietnamese men","volume":"23","author":"Nguyen","year":"2022","journal-title":"Asian Pacif. J. Cancer Prevent.: APJCP"},{"key":"10.1016\/j.ctarc.2024.100845_bib0070","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2020004","article-title":"Risk factors for stomach cancer: a systematic review and meta-analysis","volume":"42","author":"Poorolajal","year":"2020","journal-title":"Epidemiol. Health"},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0071","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/carcin\/bgl096","article-title":"Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)","volume":"27","author":"Jenab","year":"2006","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0072","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/CEJ.0000000000000290","article-title":"Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project","volume":"27","author":"Praud","year":"2018","journal-title":"Eur. J. Cancer Prevent."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0073","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5009\/gnl220491","article-title":"Analysis of characteristics and risk factors of patients with single gastric cancer and synchronous multiple gastric cancer among 14,603 patients","volume":"18","author":"Kim","year":"2024","journal-title":"Gut. Liver."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0074","doi-asserted-by":"crossref","first-page":"807","DOI":"10.31557\/APJCP.2022.23.3.807","article-title":"Determining gastric cancer-related risk factors in Mongolian population using ABC (D) method: a matched case-control study","volume":"23","author":"Dondov","year":"2022","journal-title":"Asian Pacif. J. Cancer Preven.: APJCP"},{"key":"10.1016\/j.ctarc.2024.100845_bib0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s12029-020-00478-w","article-title":"Clinicopathological characteristics and incidence of gastric cancer in Eastern India: a Retrospective Study","volume":"52","author":"Ghosh","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610495","article-title":"Interaction between vascular endothelial growth factor gene polymorphism and smoking on gastric cancer risk in Chinese Han population","volume":"28","author":"Wang","year":"2022","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0077","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/01635581.2022.2147274","article-title":"Association of dietary antioxidant vitamin intake and gastric cancer risk according to smoking status and histological subtypes of gastric cancer: a case-control study in Korea","volume":"75","author":"Kim","year":"2023","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0078","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2022086","article-title":"The risk of gastric cancer according to changes in smoking status among Korean men","volume":"44","author":"Park","year":"2022","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.ctarc.2024.100845_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101630","article-title":"Risk factors for gastric precancerous and cancers lesions in Latin American counties with difference gastric cancer risk","volume":"64","author":"Flores-Luna","year":"2020","journal-title":"Cancer Epidemiol."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0080","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cac2.12220","article-title":"A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors","volume":"41","author":"Lu","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ctarc.2024.100845_bib0081","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10552-008-9132-y","article-title":"Smoking and gastric cancer: systematic review and meta-analysis of cohort studies","volume":"19","author":"Ladeiras-Lopes","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0082","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21873\/invivo.13414","article-title":"The significant contribution of interleukin-16 genotypes, smoking, alcohol drinking, and helicobacter pylori infection to gastric cancer","volume":"38","author":"Fu","year":"2024","journal-title":"In. Vivo (Brooklyn)"},{"issue":"9","key":"10.1016\/j.ctarc.2024.100845_bib0083","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/nu14091764","article-title":"Diet and risk of gastric cancer: an umbrella review","volume":"14","author":"Bouras","year":"2022","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.ctarc.2024.100845_bib0084","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1097\/CM9.0000000000001652","article-title":"Risk factors for gastric cancer: a large-scale, population-based case-control study","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin. Med. J."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.alcohol.2008.04.005","article-title":"Gender differences in gastric cancer incidence in elderly former drinkers","volume":"42","author":"Song","year":"2008","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0086","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1470-2045(21)00279-5","article-title":"Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study","volume":"22","author":"Rumgay","year":"2021","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0087","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260019","article-title":"Alcohol consumption and the risk of gastric intestinal metaplasia in a US Veterans population","volume":"16","author":"Holmes","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0088","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/ijc.33504","article-title":"Lifetime alcohol intake, drinking patterns over time and risk of stomach cancer: a pooled analysis of data from two prospective cohort studies","volume":"148","author":"Jayasekara","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0089","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2188\/jea.JE20190304","article-title":"Alcohol consumption and risk of gastric cancer: the Japan collaborative cohort study","volume":"31","author":"Li","year":"2021","journal-title":"J. Epidemiol."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20382","article-title":"Association of the frequency and quantity of alcohol consumption with gastrointestinal cancer","volume":"4","author":"Yoo","year":"2021","journal-title":"JAMa Netw. Open."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0091","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/carcin\/bgab114","article-title":"Gastric tumorigenesis induced by combining Helicobacter pylori infection and chronic alcohol through IL-10 inhibition","volume":"43","author":"Aziz","year":"2022","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ctarc.2024.100845_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41021-021-00201-6","article-title":"Free radical-mediated acetaldehyde formation by model reactions of dietary components: effects of meat, wine, cooking oil and coffee","volume":"43","author":"Kasai","year":"2021","journal-title":"Genes Environ."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0093","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.3390\/nu13113927","article-title":"Association between coffee consumption\/physical exercise and gastric, hepatic, colon, breast, uterine cervix, lung, thyroid, prostate, and bladder cancer","volume":"13","author":"Kim","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0094","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clinre.2014.09.005","article-title":"Coffee consumption and risk of gastric cancer: an updated meta-analysis","volume":"39","author":"Shen","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/CEJ.0000000000000680","article-title":"Coffee consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling Project consortium","volume":"31","author":"Martimianaki","year":"2022","journal-title":"Eur. J. Cancer Prevent."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0096","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.24445","article-title":"High-temperature beverages and foods and esophageal cancer risk\u2014A systematic review","volume":"125","author":"Islami","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0097","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/cancers15102778","article-title":"Gastric cancer risk in association with underweight, overweight, and obesity: a systematic review and meta-analysis","volume":"15","author":"Azizi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0098","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000515444","article-title":"Excess body weight and gastrointestinal cancer risk","volume":"37","author":"Scher\u00fcbl","year":"2021","journal-title":"Visc. Med."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0099","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1158\/1055-9965.EPI-13-0042","article-title":"Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies","volume":"22","author":"Chen","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100845_bib0100","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1158\/1055-9965.EPI-22-0051","article-title":"Association between body mass index and risk of gastric cancer by anatomic and histologic subtypes in over 500,000 east and southeast Asian cohort participants","volume":"31","author":"Jang","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0101","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/ijpvm.IJPVM_153_19","article-title":"Role of obesity in the tumorigenesis of gastric cancer","volume":"11","author":"Mohammadi","year":"2020","journal-title":"Int. J. Prev. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0102","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1111\/jgh.15558","article-title":"Association between obesity and the risk of gastric cancer in premenopausal and postmenopausal women: a nationwide cohort study","volume":"36","author":"Choi","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0103","first-page":"238","article-title":"Association between metabolically healthy status and risk of gastrointestinal cancer","volume":"56","author":"Cui","year":"2024","journal-title":"Cancer Res. Treat. Off. J. Korean Cancer Assoc."},{"key":"10.1016\/j.ctarc.2024.100845_bib0104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-019-0472-2","article-title":"Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study","volume":"20","author":"Hashimoto","year":"2020","journal-title":"BMC. Endocr. Disord."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100845_bib0105","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1111\/cas.15805","article-title":"Body mass index and esophageal and gastric cancer: a pooled analysis of 10 population-based cohort studies in Japan","volume":"114","author":"Koyanagi","year":"2023","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0106","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014Viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240413","article-title":"Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort","volume":"15","author":"Sanikini","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0108","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/CEJ.0000000000000657","article-title":"Obesity and incident gastrointestinal cancers: overall body size or central obesity measures, which factor matters?","volume":"30","author":"Madani","year":"2021","journal-title":"Eur. J. Cancer Prevent."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0109","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0110","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dsx.2019.01.041","article-title":"How the association between obesity and inflammation may lead to insulin resistance and cancer","volume":"13","author":"Amin","year":"2019","journal-title":"Diabet. Metab. Syndr.: Clin. Res. Rev."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0111","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/nu14112233","article-title":"Gastric cancer risk was associated with dietary factors irritating the stomach wall: a case\u2013control Study in Korea","volume":"14","author":"Kim","year":"2022","journal-title":"Nutrients"},{"issue":"19","key":"10.1016\/j.ctarc.2024.100845_bib0112","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.7314\/APJCP.2014.15.19.8509","article-title":"Diet and cancer risk in the Korean population: a meta-analysis","volume":"15","author":"Woo","year":"2014","journal-title":"Asian Pacif. J. Cancer Prevent."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0113","first-page":"588","article-title":"Diet and carcinogenesis of gastric cancer","volume":"38","author":"Maddineni","year":"2022","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0114","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5202946","article-title":"Dietary risk factors associated with development of gastric cancer in Nepal: a hospital-based case-control study","volume":"2020","author":"Shah","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0115","first-page":"1790","article-title":"Dietary factors and the risk of gastric cancer in Hanzhong Area of China","volume":"51","author":"Wang","year":"2022","journal-title":"Iran. J. Public Health"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0116","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/nu13041365","article-title":"Gastric cancer and the daily intake of the major dish groups contributing to sodium intake: a case-control study in Korea","volume":"13","author":"Kwak","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3164\/jcbn.19-65","article-title":"Estimation of salt intake from spot urine may assist the risk assessment of gastric cancer","volume":"66","author":"Goto","year":"2020","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.ctarc.2024.100845_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.129697","article-title":"Red and processed meat consumption and cancer outcomes: umbrella review","volume":"356","author":"Huang","year":"2021","journal-title":"Food Chem."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0119","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/nu11040826","article-title":"Effect of red, processed, and white meat consumption on the risk of gastric cancer: an overall and dose\u2013response meta-analysis","volume":"11","author":"Kim","year":"2019","journal-title":"Nutrients"},{"issue":"18","key":"10.1016\/j.ctarc.2024.100845_bib0120","doi-asserted-by":"crossref","first-page":"30563","DOI":"10.18632\/oncotarget.15699","article-title":"Red and processed meat consumption and gastric cancer risk: a systematic review and meta-analysis","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0121","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.dld.2023.02.021","article-title":"Sex-specific effects of fruit, vegetable, and red meat intake on the risk of gastric and esophageal cancer in a large cohort","volume":"55","author":"Nam","year":"2023","journal-title":"Digest. Liver Dis."},{"key":"10.1016\/j.ctarc.2024.100845_bib0122","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2147\/CEG.S256627","article-title":"Epidemiologic study of gastric cancer in Iran: a systematic review","author":"Kalan Farmanfarma","year":"2020","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0123","doi-asserted-by":"crossref","first-page":"e00507","DOI":"10.34172\/jrhs.2021.38","article-title":"Macronutrients intake and stomach cancer risk in Iran: a hospital-based case-control study","volume":"21","author":"Toorang","year":"2021","journal-title":"J. Res. Health Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0124","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jfma.2018.07.015","article-title":"Talc exposure and risk of stomach cancer: systematic review and meta-analysis of occupational cohort studies","volume":"119","author":"Chang","year":"2020","journal-title":"J. Formosan Med. Assoc."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0125","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/bjc.2014.599","article-title":"Stomach cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies","volume":"112","author":"Fortunato","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ctarc.2024.100845_bib0126","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.3904\/kjim.2019.421","article-title":"Increased risk of gastric cancer in workers with occupational dust exposure","volume":"36","author":"Kang","year":"2021","journal-title":"Korean J. Intern. Med."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0127","first-page":"794","article-title":"Occupational exposure to crystalline silica and gastric cancer: a systematic review and meta-analysis","volume":"73","author":"Lee","year":"2016","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.ctarc.2024.100845_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116280","article-title":"A systematic review of mechanistic studies on the relationship between pesticide exposure and cancer induction","volume":"456","author":"Ataei","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/oemed-2011-100051","article-title":"Occupational dust and radiation exposure and mortality from stomach cancer among German uranium miners, 1946\u20132003","volume":"69","author":"Kreuzer","year":"2012","journal-title":"Occup. Environ. Med."},{"issue":"13","key":"10.1016\/j.ctarc.2024.100845_bib0130","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.3390\/nu15132982","article-title":"Association of fried food intake with gastric cancer risk: a systemic review and meta-analysis of case\u2013control studies","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0131","first-page":"170","article-title":"Multivariate analysis of the association between consumption of fried food and gastric cancer and precancerous lesions","volume":"52","author":"Guo","year":"2018","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0132","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/10408398.2019.1588222","article-title":"Acrylamide in human diet, its metabolism, toxicity, inactivation and the associated European Union legal regulations in food industry","volume":"60","author":"Koszucka","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0133","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12876-022-02384-w","article-title":"Clinical applicability of a new scoring system for population-based screening and risk factors of gastric cancer in the Wannan region","volume":"22","author":"Li","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0134","article-title":"Dietary patterns and risk for gastric cancer: a case-control study in residents of the Huaihe River Basin, China","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Nutrit."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0135","first-page":"401","article-title":"Relationship between serum inflammatory cytokines and lifestyle factors in gastric cancer","volume":"10","author":"Sun","year":"2019","journal-title":"Mol. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0136","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/ijc.21678","article-title":"Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC\u2013EURGAST)","volume":"118","author":"Gonz\u00e1lez","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0137","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/biom10121653","article-title":"Carotenoids in cancer metastasis\u2014Status quo and outlook","volume":"10","author":"Koklesova","year":"2020","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0138","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.3390\/cancers12103064","article-title":"Polyphenol intake and gastric cancer risk: findings from the stomach cancer pooling project (StoP)","volume":"12","author":"Vitelli-Storelli","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.ctarc.2024.100845_bib0139","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1080\/10408398.2018.1474169","article-title":"Vitamin E and its anticancer effects","volume":"59","author":"Abraham","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0140","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/nu14122373","article-title":"Macronutrients intake and risk of stomach cancer: findings from case-control study","volume":"14","author":"Allehdan","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0141","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0142","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017739","article-title":"Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden","volume":"7","author":"Brusselaers","year":"2017","journal-title":"BMJ Open."},{"issue":"49","key":"10.1016\/j.ctarc.2024.100845_bib0143","doi-asserted-by":"crossref","first-page":"e32228","DOI":"10.1097\/MD.0000000000032228","article-title":"Use of proton pump inhibitors for the risk of gastric cancer","volume":"101","author":"Gao","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ctarc.2024.100845_bib0144","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101585","article-title":"Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer","volume":"62","author":"Brusselaers","year":"2019","journal-title":"Cancer Epidemiol."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0145","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/jgh.14759","article-title":"Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: a systematic analysis","volume":"34","author":"Jiang","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"13","key":"10.1016\/j.ctarc.2024.100845_bib0146","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.3390\/cancers14133052","article-title":"Proton pump inhibitor use and risk of gastric cancer: current evidence from epidemiological studies and critical appraisal","volume":"14","author":"Poly","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctarc.2024.100845_bib0147","article-title":"Effect of frequently prescribed drugs on gastric cancer risk","volume":"50","author":"Weltermann","year":"2021","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0148","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/aje\/kwq299","article-title":"Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study","volume":"172","author":"Edgren","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0149","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15038342","article-title":"Investigating the association between XRCC1 gene polymorphisms and susceptibility to gastric cancer","volume":"15","author":"Chen","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/cr.2009.33","article-title":"A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http:\/\/analysis. bio-x. cn)","volume":"19","author":"Li","year":"2009","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0151","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/etm.2010.154","article-title":"Association between common genetic variants in pre-microRNAs and the clinicopathological characteristics and survival of gastric cancer patients","volume":"1","author":"Okubo","year":"2010","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0152","first-page":"4599","article-title":"Association between the XRCC3 Thr241Met polymorphism and gastrointestinal cancer risk: a meta-analysis","volume":"17","author":"Sahami-Fard","year":"2016","journal-title":"Asian Pacif. J. Cancer Preven.: APJCP"},{"issue":"7","key":"10.1016\/j.ctarc.2024.100845_bib0153","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jmg.2004.018275","article-title":"Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria","volume":"41","author":"Brooks-Wilson","year":"2004","journal-title":"J. Med. Genet."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100845_bib0154","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/jso.26869","article-title":"Environmental and genetic risk factors for gastric cancer","volume":"125","author":"Shah","year":"2022","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.14228","article-title":"Recent advances in the pathology of heritable gastric cancer syndromes","volume":"78","author":"Gullo","year":"2021","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0156","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers","volume":"52","author":"van der Post","year":"2015","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0157","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol."},{"issue":"15","key":"10.1016\/j.ctarc.2024.100845_bib0158","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.3390\/cancers13153844","article-title":"Family history and gastric cancer risk: a pooled investigation in the stomach cancer pooling (STOP) project consortium","volume":"13","author":"Vitelli-Storelli","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0159","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bjc.6605380","article-title":"Family history and the risk of gastric cancer","volume":"102","author":"Yaghoobi","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bpg.2014.09.007","article-title":"Hereditary diffuse gastric cancer\u2013Pathophysiology and clinical management","volume":"28","author":"Pinheiro","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0161","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-94-007-6570-2_2","article-title":"Frequency of familial gastric cancer","author":"Corso","year":"2013","journal-title":"Spotlight Familial Hered. Gastr. Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0162","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.774530","article-title":"Healthy lifestyle factors, cancer family history, and gastric cancer risk: a population-based case-control study in China","volume":"8","author":"Man","year":"2021","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0163","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s11126-020-09869-5","article-title":"Longitudinal assessment of prevalence and risk factors of anxiety and depression among prostate cancer survivors post-resection","volume":"92","author":"Yu","year":"2021","journal-title":"Psychiat. Q."},{"key":"10.1016\/j.ctarc.2024.100845_bib0164","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10120-018-0807-0","article-title":"Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population","volume":"21","author":"Song","year":"2018","journal-title":"Gastric Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","article-title":"Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0166","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2024.100845_bib0167","series-title":"Seminars in Immunology","article-title":"Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans","author":"Solana","year":"2012"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0168","first-page":"477","article-title":"Helicobacter pylori and gastric cancer: state of the art","volume":"5","author":"Correa","year":"1996","journal-title":"Cancer Epidemiol. Biomark. Prevent.: Publ. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ctarc.2024.100845_bib0169","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10120-016-0603-7","article-title":"A rising trend in the incidence of advanced gastric cancer in young Hispanic men","volume":"20","author":"Merchant","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0170","first-page":"1","article-title":"Smoking status and subsequent gastric cancer risk in men compared with women: a meta-analysis of prospective observational studies","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0171","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.EPI-11-0834","article-title":"Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis","volume":"21","author":"Camargo","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100845_bib0172","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/1055-9965.EPI-23-0039","article-title":"Circulating sex hormone levels and risk of gastrointestinal cancer: systematic review and meta-analysis of prospective studies","volume":"32","author":"Liu","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0173","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jnci\/djy082","article-title":"Associations between prediagnostic concentrations of circulating sex steroid hormones and esophageal\/gastric cardia adenocarcinoma among men","volume":"111","author":"Petrick","year":"2019","journal-title":"JNCI: J. Natl. Cancer Instit."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0174","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/gutjnl-2013-305033","article-title":"The burden of stomach cancer in indigenous populations: a systematic review and global assessment","volume":"63","author":"Arnold","year":"2014","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0175","doi-asserted-by":"crossref","first-page":"13308","DOI":"10.3390\/ijms131013308","article-title":"ABO blood group system and gastric cancer: a case-control study and meta-analysis","volume":"13","author":"Wang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2024.100845_bib0176","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.biopha.2016.06.048","article-title":"The clinicopathologic significance of estrogen receptors in human gastric carcinoma","volume":"83","author":"Weso\u0142owska","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ctarc.2024.100845_bib0177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5355-4","article-title":"Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review","volume":"19","author":"Mao","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0178","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1457496919863886","article-title":"Association of ABO blood groups and risk of gastric cancer","volume":"109","author":"Yu","year":"2020","journal-title":"Scand. J. Surg."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0179","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4143\/crt.2018.146","article-title":"A comprehensive assessment of the racial and ethnic disparities in the incidence of gastric cancer in the United States, 1992-2014","volume":"51","author":"Yao","year":"2019","journal-title":"Cancer Res. Treat.: Off. J. Korean Cancer Assoc."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1158\/1940-6207.CAPR-19-0200","article-title":"Racial\/ethnic patterns of young-onset noncardia gastric cancer","volume":"12","author":"Holowatyj","year":"2019","journal-title":"Cancer Prevent. Res."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0181","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cam4.4997","article-title":"Racial\/ethnic disparities in gastric cancer: a 15-year population-based analysis","volume":"12","author":"Gonzalez-Pons","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0182","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2018.09.045","article-title":"Race\/ethnicity-, socioeconomic status-, and anatomic subsite-specific risks for gastric cancer","volume":"156","author":"Gupta","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0183","doi-asserted-by":"crossref","first-page":"775","DOI":"10.31557\/APJCP.2019.20.3.775","article-title":"Risk factors of gastric cancer in high-risk region of China: a population-based case-control study","volume":"20","author":"Chen","year":"2019","journal-title":"Asian Pacif. J. Cancer Preven.: APJCP"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0184","doi-asserted-by":"crossref","first-page":"695","DOI":"10.21147\/j.issn.1000-9604.2020.06.03","article-title":"Gastric cancer: epidemiology, risk factors and prevention strategies","volume":"32","author":"Yang","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.ctarc.2024.100845_bib0185","first-page":"1","article-title":"Adding salt to food at table as an indicator of gastric cancer risk among adults: a prospective study","author":"Kronsteiner-Gicevic","year":"2024","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0186","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ijc.33678","article-title":"Exploring the interactions between Helicobacter pylori (Hp) infection and other risk factors of gastric cancer: a pooled analysis in the Stomach cancer Pooling (StoP) Project","volume":"149","author":"Collatuzzo","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0187","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/gutjnl-2019-318760","article-title":"Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations","volume":"69","author":"Yan","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0188","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3322\/caac.21555","article-title":"Cancer statistics for african Americans, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0189","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","article-title":"Hereditary diffuse gastric cancer: updated clinical practice guidelines","volume":"21","author":"Blair","year":"2020","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.explore.2018.08.001","article-title":"The effect of progressive muscle relaxation on emotional competence: depression\u2013anxiety\u2013stress, sense of coherence, health-related quality of life, and well-being of unemployed people in Greece: an intervention study","volume":"15","author":"Merakou","year":"2019","journal-title":"Explore"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0191","doi-asserted-by":"crossref","first-page":"e13129","DOI":"10.1111\/ecc.13129","article-title":"Age and gender differences in anxiety and depression in cancer patients compared with the general population","volume":"28","author":"Hinz","year":"2019","journal-title":"Eur. J. Cancer Care (Engl.)"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0192","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/CEJ.0000000000000703","article-title":"The association between diabetes and gastric cancer: results from the Stomach Cancer Pooling Project Consortium","volume":"31","author":"Dabo","year":"2022","journal-title":"Eur. J. Cancer Prevent."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100845_bib0193","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3748\/wjg.v20.i7.1701","article-title":"Diabetes and gastric cancer: the potential links","volume":"20","author":"Tseng","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0194","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/jrms.JRMS_242_19","article-title":"Diabetes and cancer: a comprehensive review","volume":"24","author":"Abudawood","year":"2019","journal-title":"J. Res. Med. Sci."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0195","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.31557\/APJCP.2022.23.5.1523","article-title":"Diabetes history and gastric cancer risk: different results by types of follow-up studies","volume":"23","author":"Bae","year":"2022","journal-title":"Asian Pacif. J. Cancer Preven.: APJCP"},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0196","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41416-019-0470-1","article-title":"Prediabetes and diabetes in relation to risk of gastric adenocarcinoma","volume":"120","author":"Zheng","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0197","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10552-012-0110-z","article-title":"Risk factors for gastric cancer in Latin America: a meta-analysis","volume":"24","author":"Bonequi","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ctarc.2024.100845_bib0198","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10552-012-0114-8","article-title":"Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America","volume":"24","author":"Torres","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"16","key":"10.1016\/j.ctarc.2024.100845_bib0199","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.7314\/APJCP.2015.16.16.6889","article-title":"Analysis of relationships between altitude and distance from volcano with stomach Cancer incidence using a geographic information system","volume":"16","author":"Amani","year":"2015","journal-title":"Asian Pacif. J. Cancer Prevent."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0200","first-page":"188","article-title":"Cancer risk associated with living at high altitude in Ecuadorian population from 2005 to 2014","volume":"91","author":"Garrido","year":"2018","journal-title":"Clujul Med."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100845_bib0201","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1054\/bjoc.2001.1994","article-title":"A minimum estimate for the incidence of gastric cancer in Eastern Kenya","volume":"85","author":"McFarlane","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0202","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/0016-5085(93)90370-R","article-title":"Prolonged achlorhydria and gastric neoplasia: is there a causal relationship?","volume":"104","author":"Lechago","year":"1993","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0203","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1349-7006.1992.tb02736.x","article-title":"A prospective study of atrophic gastritis and stomach cancer risk","volume":"83","author":"Kato","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100845_bib0204","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4251\/wjgo.v11.i9.665","article-title":"Premalignant lesions and gastric cancer: current understanding","volume":"11","author":"Koulis","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0205","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.3390\/ijms22126548","article-title":"Gastritis, gastric polyps and gastric cancer","volume":"22","author":"Waldum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2024.100845_bib0206","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1245\/s10434-008-9871-8","article-title":"Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy","volume":"15","author":"Ahn","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"22","key":"10.1016\/j.ctarc.2024.100845_bib0207","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.3748\/wjg.v18.i22.2832","article-title":"Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy","volume":"18","author":"Komatsu","year":"2012","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"38","key":"10.1016\/j.ctarc.2024.100845_bib0208","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.3748\/wjg.v20.i38.13734","article-title":"Gastric cancer arising from the remnant stomach after distal gastrectomy: a review","volume":"20","author":"Takeno","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0209","doi-asserted-by":"crossref","first-page":"E1048","DOI":"10.1002\/ijc.27614","article-title":"Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population-based study","volume":"131","author":"Lagergren","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.20892\/j.issn.2095-3941.2016.0011","article-title":"Influence of obesity and bariatric surgery on gastric cancer","volume":"13","author":"Dantas","year":"2016","journal-title":"Cancer Biol. Med."},{"issue":"16","key":"10.1016\/j.ctarc.2024.100845_bib0211","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.ejca.2009.08.009","article-title":"The importance of early symptom recognition in the context of early detection and cancer survival","volume":"45","author":"Ott","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0212","article-title":"Cultural, social, and healthcare access factors associated with delays in gastric cancer presentation, diagnosis, and treatment: a cross-sectional study","volume":"28","author":"Brito Filho","year":"2021","journal-title":"J. Cancer Policy."},{"issue":"18","key":"10.1016\/j.ctarc.2024.100845_bib0213","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1002\/cam4.4175","article-title":"Gastric adenocarcinoma burden and late-stage diagnosis in Latino and non-Latino populations in the United States and Texas, during 2004\u20132016: a multilevel analysis","volume":"10","author":"Parma","year":"2021","journal-title":"Cancer Med."},{"issue":"253","key":"10.1016\/j.ctarc.2024.100845_bib0214","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009725","article-title":"Point-of-care and point-of-procedure optical imaging technologies for primary care and global health","volume":"6","author":"Boppart","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ctarc.2024.100845_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/JTEHM.2017.2761764","article-title":"The role of affordable, point-of-care technologies for cancer care in low-and middle-income countries: a review and commentary","volume":"5","author":"Haney","year":"2017","journal-title":"IEEE J. Transl. Eng. Health Med."},{"issue":"17","key":"10.1016\/j.ctarc.2024.100845_bib0216","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1001\/jama.2010.553","article-title":"Gastric cancer\u2014An enigmatic and heterogeneous disease","volume":"303","author":"Shah","year":"2010","journal-title":"JAMa"},{"issue":"10251","key":"10.1016\/j.ctarc.2024.100845_bib0217","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0218","article-title":"Chemotherapy for advanced gastric cancer","author":"Wagner","year":"2017","journal-title":"Cochr. Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0219","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11938-023-00430-4","article-title":"How to improve the efficacy of gastric cancer screening?","volume":"21","author":"Januszewicz","year":"2023","journal-title":"Curr. Treat. Options. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cac2.12516","article-title":"The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023","volume":"44","author":"Wang","year":"2024","journal-title":"Cancer Commun."},{"issue":"37","key":"10.1016\/j.ctarc.2024.100845_bib0221","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.3748\/wjg.v21.i37.10510","article-title":"Challenges of deciphering gastric cancer heterogeneity","volume":"21","author":"Hudler","year":"2015","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.ctarc.2024.100845_bib0222","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2020.01.02","article-title":"Diffuse gastric cancer: histologic, molecular, and genetic basis of disease","volume":"5","author":"Iyer","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0223","doi-asserted-by":"crossref","first-page":"12983","DOI":"10.1038\/ncomms12983","article-title":"Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity","volume":"7","author":"Ooi","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0224","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/2159-8290.CD-20-1408","article-title":"Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): a phase II study evaluating an individualized treatment strategy for metastatic disease","volume":"11","author":"Catenacci","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/2159-8290.CD-17-0395","article-title":"Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma","volume":"8","author":"Pectasides","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1134\/S0026893323010041","article-title":"Landscape of KRAS, BRAF, and PIK3CA mutations and clinical features of EBV-associated and microsatellite unstable gastric cancer","volume":"57","author":"Danishevich","year":"2023","journal-title":"Mol. Biol. (N.Y.)"},{"issue":"24","key":"10.1016\/j.ctarc.2024.100845_bib0227","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.3390\/ijms21249400","article-title":"Overview of epstein\u2013barr-virus-associated gastric cancer correlated with prognostic classification and development of therapeutic options","volume":"21","author":"De Re","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0228","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41416-021-01587-4","article-title":"Diverse \u2018just-right'levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer","volume":"125","author":"Kohlruss","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0229","first-page":"118","article-title":"Gastric cancer\u2014A convergence of genomic heterogeneity","volume":"4","author":"Tan","year":"2015","journal-title":"Transl. Gastrointest. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41379-020-0623-z","article-title":"Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST)","volume":"34","author":"Atiq","year":"2021","journal-title":"Modern Pathol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0231","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","article-title":"Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms","volume":"27","author":"La Rosa","year":"2016","journal-title":"Endocr. Pathol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0232","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol. Microbiol. Scand."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0233","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0234","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/annonc\/mdx107","article-title":"A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification","volume":"28","author":"Van Cutsem","year":"2017","journal-title":"Annal. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0235","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.csbj.2021.01.009","article-title":"Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis","volume":"19","author":"Menyh\u00e1rt","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"19","key":"10.1016\/j.ctarc.2024.100845_bib0236","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2024.100845_bib0237","doi-asserted-by":"crossref","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics data integration, interpretation, and its application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinform. Biol. Insights"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0238","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: a comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metast. Rev."},{"key":"10.1016\/j.ctarc.2024.100845_bib0239","series-title":"Seminars in Cancer Biology","article-title":"Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer","author":"Zeng","year":"2022"},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0240","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrclinonc.2013.170","article-title":"Gastric cancer\u2014Molecular and clinical dimensions","volume":"10","author":"Wadhwa","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0241","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1634\/theoncologist.2011-0311","article-title":"Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?","volume":"17","author":"Wong","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ctarc.2024.100845_bib0242","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00535-015-1125-5","article-title":"Gastric cancer stem cells: evidence, potential markers, and clinical implications","volume":"51","author":"Brungs","year":"2016","journal-title":"J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0243","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41571-022-00606-4","article-title":"New treatment strategies for advanced-stage gastrointestinal stromal tumours","volume":"19","author":"Klug","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0244","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1279011","article-title":"Platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with gastric cancer undergoing radical resection","volume":"14","author":"Zeng","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0245","first-page":"1","article-title":"Gastric adenocarcinoma","volume":"3","author":"Ajani","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ctarc.2024.100845_bib0246","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9512707","article-title":"Gastric cancer in young adults: a different clinical entity from carcinogenesis to prognosis","volume":"2020","author":"Li","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"issue":"7517","key":"10.1016\/j.ctarc.2024.100845_bib0247","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ctarc.2024.100845_bib0248","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/jgh.15037","article-title":"Gastric cancer prevention strategies: a global perspective","volume":"35","author":"Eusebi","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0249","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1245\/s10434-019-07455-z","article-title":"Natural history of gastric cancer: observational study of gastric cancer patients not treated during follow-up","volume":"26","author":"Oh","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0250","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1002\/cncr.30881","article-title":"Stomach cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study","volume":"123","author":"Jim","year":"2017","journal-title":"Cancer"},{"issue":"9911","key":"10.1016\/j.ctarc.2024.100845_bib0251","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"},{"issue":"9742","key":"10.1016\/j.ctarc.2024.100845_bib0252","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.ctarc.2024.100845_bib0253","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.3390\/cancers13205216","article-title":"Molecular targets for gastric cancer treatment and future perspectives from a clinical and translational point of view","volume":"13","author":"Koerfer","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0254","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10120-014-0360-4","article-title":"Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma","volume":"18","author":"Nagatsuma","year":"2015","journal-title":"Gastric Cancer"},{"issue":"19","key":"10.1016\/j.ctarc.2024.100845_bib0256","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.3748\/wjg.v22.i19.4619","article-title":"HER2 testing in gastric cancer: an update","volume":"22","author":"Abrahao-Machado","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0257","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S1470-2045(14)70024-5","article-title":"Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial","volume":"15","author":"Dutton","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0258","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103501","article-title":"Out-of-pocket costs in gastrointestinal cancer patients: lack of a perfectly framed problem contributing to financial toxicity","volume":"167","author":"Bordonaro","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0259","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.734323","article-title":"Comparison of efficacy and safety of third-line treatments for advanced gastric cancer: a systematic review with Bayesian network meta-analysis","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0260","first-page":"3007","article-title":"Evaluating direct costs of gastric cancer treatment in Iran-case study in Kerman city in 2015","volume":"17","author":"Izadi","year":"2016","journal-title":"Asian Pacif. J. Cancer Prevent."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0261","doi-asserted-by":"crossref","first-page":"e33262","DOI":"10.2196\/33262","article-title":"Self-reliance, social norms, and self-stigma as barriers to psychosocial help-seeking among rural cancer survivors with cancer-related distress: qualitative interview study","volume":"6","author":"DeGuzman","year":"2022","journal-title":"JMIR Form. Res."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0262","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PPO.0000000000000339","article-title":"Psychosocial support in adolescents and young adults with cancer","volume":"24","author":"Penn","year":"2018","journal-title":"Cancer J."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0263","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MCG.0000000000000466","article-title":"The influence of gastric cancer screening on the stage at diagnosis and survival: a meta-analysis of comparative studies in the Far East","volume":"50","author":"Khanderia","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0264","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10120-016-0664-7","article-title":"Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study","volume":"20","author":"Tanabe","year":"2017","journal-title":"Gastric Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0265","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/cancers16051039","article-title":"Advanced diagnostic and therapeutic endoscopy for early gastric cancer","volume":"16","author":"Fujishiro","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"01","key":"10.1016\/j.ctarc.2024.100845_bib0266","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-1005628","article-title":"Early gastric cancer: its surveillance and natural course","volume":"27","author":"Shimizu","year":"1995","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0267","doi-asserted-by":"crossref","first-page":"168","DOI":"10.21147\/j.issn.1000-9604.2021.02.05","article-title":"Screening for gastric cancer in China: advances, challenges and visions","volume":"33","author":"Fan","year":"2021","journal-title":"Chin. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0268","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1089\/omi.2023.0015","article-title":"Gastric cancer biomarker candidates identified by machine learning and integrative bioinformatics: toward personalized medicine","volume":"27","author":"Sinnarasan","year":"2023","journal-title":"OMICS: J. Integr. Biol."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0269","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/humu.23650","article-title":"Specifications of the ACMG\/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants","volume":"39","author":"Lee","year":"2018","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","article-title":"Japanese gastric cancer treatment guidelines 2021","volume":"26","year":"2023","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0271","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4251\/wjgo.v12.i1.1","article-title":"Precision medicine for gastrointestinal cancer: recent progress and future perspective","volume":"12","author":"Matsuoka","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0272","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/acsbiomaterials.4c00606","article-title":"Recent advancements in the application of circulating tumor DNA as biomarkers for early detection of cancers","volume":"10","author":"Mishra","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ctarc.2024.100845_bib0273","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5791262","article-title":"Immunotherapeutic strategies for gastric carcinoma: a review of preclinical and clinical recent development","volume":"2017","author":"Abozeid","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ctarc.2024.100845_bib0274","article-title":"Recent progress and future perspectives of immunotherapy in advanced gastric cancer","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ags3.12184","article-title":"Advances in cancer immunotherapy for gastroenterological malignancy","volume":"2","author":"Kono","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.ctarc.2024.100845_bib0276","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.ctarc.2024.100845_bib0277","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1002\/cam4.3410","article-title":"Study and analysis of antitumor resistance mechanism of PD1\/PD-L1 immune checkpoint blocker","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0278","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3322\/caac.21657","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10111","key":"10.1016\/j.ctarc.2024.100845_bib0279","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2024.100845_bib0280","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s10120-018-0899-6","volume":"22","author":"Kato","year":"2019","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0281","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair\u2013deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0282","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/annonc\/mdy264","article-title":"Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300","volume":"29","author":"Bang","year":"2018","journal-title":"Annal. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0283","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/curroncol29030131","article-title":"Immunotherapy in gastric cancer","volume":"29","author":"H\u00f6gner","year":"2022","journal-title":"Curr. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0284","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2024.100845_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1093-3","article-title":"Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2\/STAT3\/VEGFA signaling in non-small cell lung cancer cells","volume":"38","author":"Liang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0286","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005200","article-title":"Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells","volume":"10","author":"Thelen","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2024.100845_bib0287","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153262","article-title":"Upregulated \u03b2-arrestin1 predicts poor prognosis and promotes metastasis via AKT\/ERK signaling pathway in gastric cancer","volume":"216","author":"Xu","year":"2020","journal-title":"Pathol.-Res. Pract."},{"key":"10.1016\/j.ctarc.2024.100845_bib0288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-021-03200-x","article-title":"Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report","volume":"15","author":"Takami","year":"2021","journal-title":"J. Med. Case Rep."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0289","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41417-020-00234-z","article-title":"The changing face of gastric cancer: epidemiologic trends and advances in novel therapies","volume":"28","author":"Chandra","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"11","key":"10.1016\/j.ctarc.2024.100845_bib0290","doi-asserted-by":"crossref","first-page":"e3550","DOI":"10.1002\/jgm.3550","article-title":"Gene therapy in cancer","volume":"25","author":"Cesur-Erg\u00fcn","year":"2023","journal-title":"J. Gene Med."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0291","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/10915360050138585","article-title":"Adenovirus-mediated p53 gene therapy for human cancer","volume":"4","author":"Fujiwara","year":"2000","journal-title":"Mol. Urol."},{"issue":"33","key":"10.1016\/j.ctarc.2024.100845_bib0292","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0293","series-title":"Pembrolizumab Plus Trastuzumab and Chemotherapy For HER2+ Metastatic Gastric Or Gastroesophageal Junction (G\/GEJ) cancer: Initial findings of the Global Phase 3 KEYNOTE-811 Study","author":"Janjigian","year":"2021"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0294","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0295","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.34511","article-title":"Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real-world cohort","volume":"153","author":"M\u00f6hring","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0296","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/jcrt.jcrt_672_22","article-title":"Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: a single-center experience","volume":"19","author":"Tastekin","year":"2023","journal-title":"J. Cancer Res. Ther."},{"issue":"9813","key":"10.1016\/j.ctarc.2024.100845_bib0297","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","article-title":"Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial","volume":"379","author":"Bang","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0298","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12029-023-00991-8","article-title":"Survival benefit of induction chemotherapy with paclitaxel and carboplatin followed by chemoradiation versus postoperative treatment in locally advanced gastric cancer: a retrospective cohort study","volume":"55","author":"Azadeh","year":"2024","journal-title":"J. Gastrointest. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0299","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","article-title":"Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial","volume":"19","author":"Cats","year":"2018","journal-title":"Lancet Oncol."},{"issue":"10184","key":"10.1016\/j.ctarc.2024.100845_bib0300","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2024.100845_bib0301","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1245\/s10434-017-5830-6","article-title":"TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an international, intergroup trial of the AGITG, TROG, EORTC and CCTG","volume":"24","author":"Leong","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4770-2","volume":"18","author":"Slagter","year":"2018","journal-title":"BMC Cancer"},{"issue":"15 Suppl","key":"10.1016\/j.ctarc.2024.100845_bib0303","article-title":"MATTERHORN: efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer\u2014A randomized, double-blind, placebo-controlled, phase 3 study","volume":"39","author":"Janjigian","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0304","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compreh. Cancer Netw."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100845_bib0305","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606","volume":"33","author":"Lordick","year":"2022","journal-title":"Annal. Oncol."},{"issue":"7890","key":"10.1016\/j.ctarc.2024.100845_bib0306","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","article-title":"The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer","volume":"600","author":"Janjigian","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0307","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/cancers14041054","article-title":"The new era of immunotherapy in gastric cancer","volume":"14","author":"Takei","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0308","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","article-title":"Current developments in gastric cancer: from molecular profiling to treatment strategy","volume":"20","author":"Alsina","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0309","article-title":"HER2-targeted therapies in gastric cancer","volume":"1876","author":"Zhu","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100845_bib0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/path.6046","article-title":"Advancing gastric cancer precision medicine with novel genomic screens","volume":"259","author":"Halmai","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0311","series-title":"First-line (1L) Nivolumab (NIVO) Plus Chemotherapy (chemo) Versus Chemo in Advanced Gastric Cancer\/Gastroesophageal Junction Cancer\/Esophageal Adenocarcinoma (GC\/GEJC\/EAC): Expanded efficacy and Safety Data from CheckMate 649","author":"Moehler","year":"2021"},{"key":"10.1016\/j.ctarc.2024.100845_bib0312","doi-asserted-by":"crossref","first-page":"S1044","DOI":"10.1016\/j.annonc.2021.08.1489","article-title":"1380P Phase (Ph) II study of zanidatamab+ chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA)","volume":"32","author":"Ku","year":"2021","journal-title":"Annal. Oncol."},{"issue":"29","key":"10.1016\/j.ctarc.2024.100845_bib0313","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2217\/fon-2022-0595","article-title":"HERIZON-GEA-01: zanidatamab+ chemo\u00b1tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma","volume":"18","author":"Tabernero","year":"2022","journal-title":"Fut. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0314","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-015-0638-9","article-title":"Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial","volume":"16","author":"Straatman","year":"2015","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.ctarc.2024.100845_bib0315","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1245\/s10434-023-13654-6","article-title":"Minimally invasive and open gastrectomy for gastric cancer: a systematic review and network meta-analysis of randomized clinical trials","volume":"30","author":"Davey","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0316","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1245\/s10434-020-08864-1","article-title":"Chemotherapy versus chemotherapy plus chemoradiation as preoperative therapy for resectable gastric adenocarcinoma: a propensity score-matched analysis of a large, single-institution experience","volume":"28","author":"Allen","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0317","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1245\/s10434-016-5645-x","article-title":"Race is a risk for lymph node metastasis in patients with gastric cancer","volume":"24","author":"Ikoma","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100845_bib0318","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamasurg.2022.0182","article-title":"Surgical management of gastric cancer: a review","volume":"157","author":"Li","year":"2022","journal-title":"JAMA Surg."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100845_bib0319","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/cac2.12193","article-title":"The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun."},{"issue":"13","key":"10.1016\/j.ctarc.2024.100845_bib0320","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0321","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Js","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0322","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12957-023-03018-5","article-title":"Comparison of the clinical and prognosis risk factors between endoscopic resection and radical gastrectomy for early-stage gastric cancer","volume":"21","author":"Dao","year":"2023","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0323","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamasurg.2013.3959","article-title":"Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND\/UCLA expert panel","volume":"149","author":"Brar","year":"2014","journal-title":"JAMA Surg."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0324","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1442-2050.2006.00559.x","article-title":"Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer","volume":"19","author":"Stephens","year":"2006","journal-title":"Dis. Esophagus"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0325","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/curroncol29020102","article-title":"The prognostic effect of multidisciplinary team intervention in patients with advanced gastric cancer","volume":"29","author":"Xiang","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0326","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101599","article-title":"Multidisciplinary treatment strategy for locally advanced gastric cancer: a systematic review","volume":"38","author":"Sugawara","year":"2021","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0327","unstructured":"(NCCN), N.C.C.N. NCCN Guidelines, Version 2.2020, Gastric Cancer. [cited 2020 June 15]; Available from: www.nccn.org\/."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0328","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7602\/jmis.2023.26.2.47","article-title":"What is the role of surgical oncologist in the treatment of gastric cancer?","volume":"26","author":"Song","year":"2023","journal-title":"J. Minim. Invasive Surg."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0329","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1159\/000510406","article-title":"A case of peritoneal dissemination and splenic metastasis after gastric cancer surgery that could be controlled with multidisciplinary treatment","volume":"13","author":"Karakuchi","year":"2021","journal-title":"Case Rep. Oncol."},{"key":"10.1016\/j.ctarc.2024.100845_bib0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.951137","article-title":"Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100845_bib0331","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41467-023-35797-6","article-title":"Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100845_bib0332","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/ptr.7866","article-title":"Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: recent advances and perspectives","volume":"37","author":"Hu","year":"2023","journal-title":"Phytother. Res."},{"issue":"13","key":"10.1016\/j.ctarc.2024.100845_bib0333","first-page":"1506","article-title":"Natural products and gastric cancer: cellular mechanisms and effects to change cancer progression","volume":"23","author":"Zhao","year":"2023","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem.-Anti-Cancer Agents)"},{"key":"10.1016\/j.ctarc.2024.100845_bib0334","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-020-0270-5","article-title":"Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge","volume":"15","author":"Bimonte","year":"2020","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0335","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phymed.2018.06.014","article-title":"Andalucin from Artemisia lannta suppresses the neuroinflammation via the promotion of Nrf2-mediated HO-1 levels by blocking the p65\u2013p300 interaction in LPS-activated BV2 microglia","volume":"51","author":"Wang","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ctarc.2024.100845_bib0336","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13020-017-0140-2","article-title":"Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine","volume":"12","author":"Zhang","year":"2017","journal-title":"Chin. Med."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0337","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41419-022-04608-z","article-title":"Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer","volume":"13","author":"Zhong","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100845_bib0338","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/foods12020415","article-title":"The role of propolis as a natural product with potential gastric cancer treatment properties: a systematic review","volume":"12","author":"Rivera-Ya\u00f1ez","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.ctarc.2024.100845_bib0339","unstructured":"2022, G., International Agency for Research on Cancer, 2022."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100845_bib0340","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10120-021-01273-7","article-title":"Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study","volume":"25","author":"Takahashi","year":"2022","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ctarc.2024.100845_bib0341","first-page":"1","article-title":"Gastric cancer incidence and mortality in French Guiana: South American or French?","author":"Imounga","year":"2022","journal-title":"J. Gastrointest. Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:15:05Z","timestamp":1733040905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294224000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":341,"alternative-id":["S2468294224000571"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100845","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100845"}}